Drug Type siRNA |
Synonyms FB 7013, FB7013 |
Target |
Action inhibitors |
Mechanism MASP2 inhibitors(Mannan-binding lectin serine protease 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glomerulonephritis, IGA | IND Application | China | 31 Dec 2025 |





